MedPath

Found 556413 clinical trials

Sort by:

The Safety and Efficacy of Irreversible Electroporation for the Treatment of Perivascular Liver Cancers

Not Applicable

Active, not recruiting

Conditions: Liver Cancer
Ablation Techniques
Radiology

First Posted Date: 2025-10-09

Last Posted Date: 2025-10-09

Lead Sponsor: National Taiwan University Hospital

Target Recruit Count: 20

Registration Number: NCT07214363

Locations: 🇨🇳
National Taiwan University Hospital, Taipei, Taiwan

Safety and Efficacy of Nebulized Nitroglycerin in Pulmonary Arterial Hypertension

Not Applicable

Completed

Conditions: Pulmonary Arterial Hypertension

Interventions: Drug: Nebulized nitroglycerin

First Posted Date: 2025-10-09

Last Posted Date: 2025-10-09

Lead Sponsor: Mansoura University

Target Recruit Count: 20

Registration Number: NCT07214129

Locations: 🇪🇬
Mohamed AbdElmoniem, Al Mansurah, Egypt

Modification of Threat Interpretation Bias to Reduce Anxiety in Neurodegenerative Movement Disorders (Aim 3)

Not Applicable

Not yet recruiting

Conditions: Huntington Disease
Parkinson Disease

First Posted Date: 2025-10-09

Last Posted Date: 2025-10-09

Lead Sponsor: University of Virginia

Target Recruit Count: 136

Registration Number: NCT07213648

Locations: 🇺🇸
Univeristy of Virginia School of Nursing, Charlottesville, Virginia, United States

A Study to Assess the Bioequivalence of Trastuzumab Via Different Subcutaneous Delivery Platforms in Healthy Male Participants

Not Applicable

Not yet recruiting

Conditions: Healthy Participants

Interventions: Drug: Trastuzumab

First Posted Date: 2025-10-09

Last Posted Date: 2025-10-09

Lead Sponsor: Genentech, Inc.

Target Recruit Count: 312

Registration Number: NCT07214766

Treatment for /s/ Production Errors in Children With Speech Sound Errors

Not Applicable

Recruiting

Conditions: Speech Sound Disorder

First Posted Date: 2025-10-09

Last Posted Date: 2025-10-09

Lead Sponsor: Syracuse University

Target Recruit Count: 24

Registration Number: NCT07214480

Locations: 🇺🇸
Syracuse University, Syracuse, New York, United States

Phase I/ II Trial Combining PD-1 Inhibition and Neoadjuvant Proton or Photon Radiation Therapy in Recurrent Head and Neck Squamous Cell Carcinoma

Not Applicable

Not yet recruiting

Conditions: Head and Neck Cancer
Recurrent Head and Neck Squamous Cell Carcinoma

Interventions: Drug: Pembrolizumab
Radiation: Proton therapy

First Posted Date: 2025-10-09

Last Posted Date: 2025-10-09

Lead Sponsor: University of Cincinnati

Target Recruit Count: 40

Registration Number: NCT07213934

Locations: 🇺🇸
University of Cincinnati Medical Center, Cincinnati, Ohio, United States

Sedative and Analgesic Effects of Dexmedetomidine Versus Ketamine in Patients Undergoing Varicocelectomy Under Spinal Anaesthesia: A Prospective Randomized Comparative Trial

Not Applicable

Not yet recruiting

Conditions: Varicocelectomy

Interventions: Drug: Dexmedetomidine
Drug: Ketamine (0.5 mg/kg)

First Posted Date: 2025-10-09

Last Posted Date: 2025-10-09

Lead Sponsor: Assiut University

Target Recruit Count: 58

Registration Number: NCT07214701

UCF MammoChat: Image Repository

Recruiting

Conditions: Breast Cancer
Breast Cancer Awareness
Breast Cancer Detection
Breast Cancer Survivors
Breast Cancer Female
Breast Cancer Diagnosis

First Posted Date: 2025-10-09

Last Posted Date: 2025-10-09

Lead Sponsor: University of Central Florida

Target Recruit Count: 20000

Registration Number: NCT07214883

Locations: 🇺🇸
University of Central Florida, Orlando, Florida, United States

Enhanced Valves Interventions and Safe AI Generated End Results

Recruiting

Conditions: Heart Valve Disease
TAVI
M-TEER
TTVI
TMVI
T-TEER
Mitraclip
TriClip

First Posted Date: 2025-10-09

Last Posted Date: 2025-10-09

Lead Sponsor: Montreal Heart Institute

Target Recruit Count: 21000

Registration Number: NCT07213531

Locations: 🇺🇸
Montefiore Medical Center New York, New York, New York, United States
🇨🇦
Montreal Heart Institute, 5000 Rue Bélanger, Montréal, Montreal, Quebec, Canada
🇨🇦
St Michael's Hospital Toronto, Toronto, Canada

and more 12 locations

Bioequivalence Study to Compare Empagliflozin/Linagliptin/Metformin HCL 25mg/5mg/1000mg Extended-Release Tablets Versus Trijardy® XR Extended Release Film Coated Tablets

Not Applicable

Completed

Conditions: Type 2 Diabetes Mellitus (T2DM)

Interventions: Drug: Empagliflozin/Linagliptin/Metformin HCL
Drug: Trijardy® XR Extended release film coated tablets

First Posted Date: 2025-10-09

Last Posted Date: 2025-10-09

Lead Sponsor: Humanis Saglık Anonim Sirketi

Target Recruit Count: 14

Registration Number: NCT07213895

Locations: 🇯🇴
ACDIMA Center, Amman, Jordan

AI-Powered Research

Premium Access

The Safety and Efficacy of Irreversible Electroporation for the Treatment of Perivascular Liver Cancers

Safety and Efficacy of Nebulized Nitroglycerin in Pulmonary Arterial Hypertension

Modification of Threat Interpretation Bias to Reduce Anxiety in Neurodegenerative Movement Disorders (Aim 3)

A Study to Assess the Bioequivalence of Trastuzumab Via Different Subcutaneous Delivery Platforms in Healthy Male Participants

Treatment for /s/ Production Errors in Children With Speech Sound Errors

Phase I/ II Trial Combining PD-1 Inhibition and Neoadjuvant Proton or Photon Radiation Therapy in Recurrent Head and Neck Squamous Cell Carcinoma

Sedative and Analgesic Effects of Dexmedetomidine Versus Ketamine in Patients Undergoing Varicocelectomy Under Spinal Anaesthesia: A Prospective Randomized Comparative Trial

UCF MammoChat: Image Repository

Enhanced Valves Interventions and Safe AI Generated End Results

Bioequivalence Study to Compare Empagliflozin/Linagliptin/Metformin HCL 25mg/5mg/1000mg Extended-Release Tablets Versus Trijardy® XR Extended Release Film Coated Tablets

Product

Company

Legal